Murine models of renal disease: Possibilities and problems in studies using mutant mice

Experimental Nephrology

Volumn 8, Issue 4-5, 2000, Pages 181-193

  Anders, Hans Joachim ^a   Schlöndorff, Detlef ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Backcrossing; Glomerulonephritis; Glomerulosclerosis; Interstitial nephritis; Renal disease; Renovascular hypertension; Transgenic mice

Indexed keywords

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; CLINICAL FEATURE; DIABETIC NEPHROPATHY; GENE DELETION; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KNOCKOUT MOUSE; MOUSE; NEPHROTIC SYNDROME; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; REVIEW; TRANSGENIC MOUSE;

EID: 0342955726     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020667     Document Type: Review

References (150)

1. Salant DJ, Cybulsky AV: Experimental glomerulonephritis. Methods Enzymol 1988;162: 421-461.
2. Shapell SB, Gurpinar T, Lechago J, Suk WN, Truong LD: Chronic obstructive uropathy in severe combined immunodeficient (SCID) mice: Lymphocyte infiltration is not required for progressive tubulointerstitial injury. J Am Soc Nephrol 1998;9:1008-1017.
3. Robinson RR, Dennis VW: Spontaneously occurring animal models of human kidney diseases and altered renal function. Adv Nephrol Necker Hosp 1980;9:315-366.
4. Schieren G, Pey R, Bach J, Hafner M, Gretz N: Murine models of polycystic kidney disease. Nephrol Dial Transplant 1996;11(suppl 6):38-45.
5. Velasquez MT, Kimmel PL, Michaelis OE 4th: Animal models of spontaneous diabetic kidney disease. FASEB J 1990;4:2850-2859.
6. Majzoub JA, Muglia LJ: Knockout mice. N Engl J Med 1996;34:904-907.
7. Wang T, Giebisch G: Tubule function in transgenic mice. Exp Nephrol 1998;6:447-453.
8. Raabe M, Flynn LM, Zlot CH, Wong JS, Veniant MM, Hamilton RL, Young SG: Knock-out of the abetalipoproteinemia gene in mice: Reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes. Proc Natl Acad Sci USA 1998;95:8686-8691.
9. Farese RV Jr, Ruland SL, Flynn LM, Stokowski RP, Young SG: Knockout of the mouse apolipoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozygotes. Proc Natl Acad Sci USA 1995;28:1774-1778.
10. Rajewsky K, Gu H, Kuhn R, Betz UA, Muller W, Roes J, Schwenk F: Conditional gene targeting. J Clin Invest 1996;98:600-603.
11. Ryffel B: Gene knockout mice as investigative tools in pathophysiology. Int J Exp Pathol 1996;77:125-141.
12. Kitamura M: Transfer of genetically engineered cells to the glomerulus. Exp Nephrol 1997;7:259-266.
13. Lakkis FG: Role of cytokines in tansplantation tolerance: Lessons learned from gene-knockout mice. J Am Soc Nephrol 1998;9:2361-2367.
14. Lathe R: Mice, gene targeting, and behaviour: More than just genetic background. Trends Neurosci 1996;19:183-186.
15. Banbury Conference on Genetic Background in Mice: Mutant mice and neuroscience: Recommendations concerning genetic background. Neuron 1997;19:755-759.
16. Gerlai R: Gene-targeting studies of mammalian behavior: Is it the mutation or the background genotype? Trends Neurosci 1996;19: 177-181.
17. Furth PA, St Onge L, Boger H, Gruss P, Gossen M, Kistner A, Bujard H, Henninghausen L: Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Aead Sci USA 1994;91:9302-9306.
18. Lakso M, Sauer B, Mosinger B Jr: Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci USA 1992;89:6232-6236.
19. Gu H, Marth JD, Orban PC, Mossmann H, Rajewsky K: Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 1994;265:103-106.
20. Schwenk F, Kuhn R, Angrand PO, Rajewsky K, Stewart AF: Temporally and spatially regulated somatic mutagenesis in mice. Nucleic Acids Res 1998;26:1427-1432.
21. Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, Moates JM, Shelton KD, Lindner J, Cherrington AD, Magnuson MA: Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Crc recombinase. J Biol Chem 1999;274:305-315.
22. Jaisser F, Beggah AT: Transgcnic models in renal tubular physiology. Exp Nephrol 1998;6: 438-446.
23. Furness PN, Harris K: An evaluation of experimental models of glomerulonephritis. Int J Exp Pathol 1994;75:9-22.
24. Noble B, Brentjens JR: Experimental serum sickness. Methods Enzymol 1988;162:484-901.
25. Furness PN: The formation and fate of glomerular immune complex deposits. J Pathol 1991; 164:195-202.
26. Germuth FG, Rodrigucz E, Lorelle CA, Trump El. Milano L, Wise O: Passive immune complex glomerulonephritis in mice: Models for various lesions found in human diseases. I. High avidity complexes and mesangiopathic glomerulonephritis. Lab Invest 1979;41:360-365.
27. Noble B, Olson KA, Milgrom M, Albini B: Tissue deposition of immune complexes in mice receiving daily injections of bovine serum albumin. Clin Exp Immunol 1980;42:255-262.
28. Hagstrom GL, Bloom BM, Yum MN, Lavelle KJ, Luft FC: Ferritin-and apoferritin-induced immune complex glomerulonephritis in mice. Nephron 1979;24:127-133.
29. Iskandar SS, Gifford DR, Emancipator SN: Immune complex acute necrotizing glomerulonephritis with progression to diffuse glomerulosclerosis: A murine model. Lab Invest 1988; 59:772-779.
30. Iskandar SS, Jennette JC, Wilkman AS, Beeker RL: Interstrain variations in nephritogenicity of heterologous protein in mice. Lab Invest 1982;46:344-351.
31. Iskandar SS, Jennette JC: Influence of antibody avidity on glomerular immune complex localization. Am J Pathol 1983;112:155-159.
32. Iskandar SS, Jennette JC: Interaction of antigen load and antibody response in determining heterologous protein nephritogenicity in inbred mice. Lab Invest 1983;48:726-734.
33. Falk RJ, Jcnnctte JC: Immune complex induced glomerular lesions in C5 sufficient and deficient mice. Kidney Int 1986;30:678-686.
34. Quigg RJ, Lim A, Haas M, Alexander JJ, He C, Carroll MC: Immune complex glomerulonephritis in C4-and C3-deficient mice. Kidney Int 1998;53:320-330.
35. Galla JH: IgA nepropathy. Kidney Int 1995;47: 377-387.
36. Rifai A: Experimental models of IgA-associated nephritis. Kidney Int 1987;31:1-7.
37. Coppo R, Mazzucco G, Martina G, Rocatello D. Amore A, Novara R, Bargoni A, Piccoli G, Sena LM: Gluten-induced experimental IgA glomerulopathy. Lab Invest 1989;60:499-506.
38. Emancipator SN, Gallo GR, Lamm ME: Experimental IgA nephropathy induced by oral immunization. J Exp Med 1983;157:572-582.
39. Emancipator SN, Gallo GR, Razaboni R, Lamm ME: Experimental cholestasis promotes the deposition of glomerular IgA immune complexes. Am J Pathol 1983;113:19-26.
40. Gonzales E, Gonzales-Cabrero J, Egido J: Defective hepatic handling of IgA immune aggregates by mice with experimental IgA nephropathy. Immunology 1989;67:303-313.
41. Sato M, Ideura T, Koshikawa S: Experimental IgA nephropathy in mice. Lab Invest 1986;54: 377-384.
42. Isaacs KL, Miller F: Role of antigen size and charge in immune complex glomerulonephritis. I. Active induction of disease with dextran and its derivates. Lab Invest 1982;47:198-205.
43. Isaacs KL, Miller F: Antigen size and charge in immune complex glomerulonephritis. II. Passive induction of immune deposits with dextran-anti-dextran immune complexes. Am J Pathol 1983;111:298-306.
44. Montinaro V, Aventaggiato L, Cavallo T. Rifai A: Evolution of renal injury in a chronic model of IgA immune-complex-associated nephropathy. Nephrol Dial Transplant 1995;10:2035-2042
45. Feehally J, Allen AC: Structural features of IgA molecules which contribute to IgA nephropathy. J Nephrol 1999;12:59-65.
46. Assmann KJ, Tangelder MM, Lange WP, Schrijver G, Koene RA: Anti-GBM nephritis in the mouse: Severe proteinuria in the heterologous phase. Virchovvs Arch A Pathol Anat Histopathol 1985;406:285-299.
47. Wilson CB: Immune models of glomerular injury: in Neilson EG, Couser WC (eds): Immunologic Renal Diseases. New York, Lippincott-Raven, 1997, pp 729-774.
48. Schrijver G, Bogman MJ, Assmann KJ, de Waal RM, Robben HJ, van Gasteren H, Koene RA: Anti-GBM nephritis in the mouse: Role of granulocytes in the heterologous phase. Kidney Int 1990;38:86-95.
49. Bolten WK, Benton FR, Sturgill BC: Autoimmune glomerulotubular nephropathy in mice. Clin Exp Immunol 1978;33:463-473.
50. Tipping PG, Huang XR, Berndt MC, Holdsworth SR: A role for P-selectin in complement-independent neutrophil-mediated glomerular injury. Kidney Int 1994;46:79-88.
51. Huang XR, Tipping PG, Shuo Li, Holdsworth S: Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice. Kidney Int 1997;51: 94-103.
52. Huang XR, Holdsworth SR, Tipping PG: Th-2 responses induce humorally mediated injury in experimental anti-glomerular basement membrane glomerulonephritis. J Am Soc Nephrol 1997;8:1101-1108.
53. Kitching AR, Holdsworth SR, Tipping PG: IFN-gamma mediates crescent formation and cell-mediated immune injury in murine glomerulonephritis. J Am Soc Nephrol 1999;10: 752-759.
54. Kitching AR, Tipping PG, Mutch DA, Huang XR, Holdsworth SR: Interleukin-4 deficiency enhances Th1 responses and crescentic glomerulonephritis in mice. Kidney Int 1998;53:112-118.
55. Janssen U, Ostendorf T, Gaertner S, Eitner F, Hedrich HJ, Assmann KJ, Floege J: Improved survival and amelioration of nephrotoxic nephritis in intercellular adhesion molecule-1 knockout mice. J Am Soc Nephrol 1998;9: 1805-1814.
56. Sheerin NS, Springall T, Carroll MC, Hartley B, Sacks SH: Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3-and C4-deficient mice. Clin Exp Immunol 1997;110:403-409.
57. Tesch GH, Schwarting A, Kinoshita K, Lan HY, Rollins BJ, Kelley VR: Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest 1999;103:73-80.
58. Cattell V, Cook HT, Ebrahim H, Waddington SN, Wei XQ, Assmann KJ, Liew FY: Anti-GBM glomerulonephritis in mice lacking nitric oxide synthase type 2. Kidney Int 1998;53: 932-936.
59. Li S, Holdsworth SR, Tipping PG: Antibody independent crescentic glomerulonephritis in mu chain deficient mice. Kidney Int 1997;51: 672-678.
60. Li S, Kurts C, Kontgen F, Holdsworth SR, Tipping PG: Major histocompatibility complex class II expression by intrinsic renal cells is required for crescentic glomerulonephritis. J Exp Med 1998;188:597-602.
61. Hisada Y, Sugaya T, Yamanouchi M, Uchida H, Fujimura H, Sakurai H, Fukamizu A, Marakami K: Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest 1999;103:627-635.
62. Ryffel B, Eugster H, Haas C, Le Hir M: Failure to induce anti-glomerular basement membrane glomerulonephritis in TNF alpha/beta deficient mice. Int J Exp Pathol 1998;79:453-460.
63. Tipping PG, Huang XR, Qi M, Van GY, Tang WW: Crescentic glomerulonephritis in CD4-and CD8-deficient mice: Requirement for CD4 but not CD8 cells. Am J Pathol 1998;152: 1541-1548.
64. Eitner F, Westerhuis R, Burg M, Weinhold B, Grone HJ, Ostendorf T, Ruther U, Koch KM, Rees AJ, Floege J: Role of interleukin-6 in mediating mesangial cell proliferation and matrix production in vivo. Kidney Int 1997;51: 69-78.
65. Cattell V, Bradfield JW: Focal mesangial proliferative glomerulonephritis in the rat caused by Habu snake venom: A morphologic study. Am J Pathol 1977;87:511-524.
66. Cattell V, Mehotra A: Focal mesangial proliferative glomerulonephritis in the rat caused by Habu venom: The effect of antiplatelcl agents. Br J Exp Pathol 1980;61:310-314.
67. Nakao H, Hiraiwa N, Yoshiki A, Ike F, Kusakabe M: Tenascin-C promotes healing of Habu-snake venom-induced glomerulonephritis: Studies in knockout congenic mice and in culture. Am J Pathol 1998;152:1237-1245.
68. Kashgarian M: Lupus nephritis: Lessons from the path lab. Kidney Int 1994;45:928-938.
69. Theofilopoulos AN, Dixon FJ: Etiopathogenesis of murine SLE. Immunol Rev 1991;55:179-216.
70. Diaz Gallo C, Jevnikar AM, Brennan DC, Florquin S, Pacheco-Silva A, Kelley VR: Autoreactive kidney-infiltrating T-cell clones in murine lupus nephritis. Kidney Int 1992;42:851-859.
71. Mohan C, Datta SK: Lupus: Key pathogenic mechanisms and contributing factors. Clin Immunol Immunopathol 1995;77:209-220.
72. Wakeland EK, Morel L, Mohan C, Yui M: Genetic dissection of lupus nephritis in murine models of SLE. J Clin Immunol 1997;17:272-281.
73. Clynes R, Dumitru C, Ravetch JV: Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 1998;279:1052-1054.
74. Haas C, Ryffel B, Le Hir M: IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB × NZW)F1 mice. J Immunol 1998;160:3713-3718.
75. Schwarting A, Wada T, Kinoshita K, Tesch G, Kelley VR: IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. J Immunol 1998;161:494-503.
76. Lloyd CM, Gonzalo JA, Salant DJ, Just J, Gutierrez-Ramos JC: Intercellular adhesion molecule-1 deficiency prolongs survival and protects against the development of pulmonary inflammation during murine lupus. J Clin Invest 1997;100:963-971.
77. Baldwin DS: Chronic glomerulonephritis: Nonimmunologic mechanisms of progressive glomerular damage. Kidney Int 1982;21:109-120.
78. Neuringer JR, Brenner BM: Hemodynamic theory of progressive renal disease: A 10-year update in brief review. Am J Kidney Dis 1992; 22:98-104.
79. Striker GE, He CJ, Liu RH, Yang DCW, Zalups RK, Esposito C, Striker EJ: Pathogenesis of nonimmune glomerulosclerosis: Studies in animals and potential applications to humans. Eab Invest 1995;73:596-605.
80. Kriz W, Elger M, Nagata M, Kretzler M, Uiker S, Koeppen-Hageman I, Tenschert S, Lemley KV: The role of podocytes in the development of glomerular sclerosis. Kidney Int 1994; 45(suppl):64-72.
81. Doi T, Striker EJ, Gibson CC, Agodoa EY, Brinster RL, Striker GE: Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis. Am J Pathol 1990;137:541-552.
82. Doi T, Striker EJ, Kimata K, Peten EP, Yamada Y, Striker GE: Glomerulosclerosis in mice transgcnic for growth hormone: Increased mesangial extracellular matrix is correlated with kidney mRNA levels. J Exp Med 1991; 173:1287-1290.
83. Wanke R, Hermanns W, Folger S, Wolf E, Brem G: Accelerated growth and visceral lesions in transgcnic mice expressing foreign genes of the growth hormone family: An overview. Pediatr Nephrol 1991;5:513-521.
84. Brem G, Wanke R, Wolf E, Buchmüller T, Müller M, Brenig B, Hermanns W: Multiple consequences of human growth hormone expression in transgenic mice. Mol Biol Med 1989;6:531-547.
85. Weiher H, Noda T, Gray DA, Sharpe AH, Jaenisch R: Transgenic mouse model of kidney disease: Insertional inactivation of ubiquitously expressed gene leads to nephrotic syndrome. Cell 1990;62:425-434.
86. MacKay K, Striker LJ, Pinkert CA, Brinster RL, Striker GE: Glomerulosclerosis and renal cysts in mice transgenic for the early region of SV40. Kidney Int 1987;32:827-837.
87. Kollias G, Evans DJ, Ritter M, Beech J, Morris R, Grosveld F: Ectopic expression of Thy-1 in the kidneys of transgenic mice induces functional and proliferative abnormalities. Cell 1987;51:21-31.
88. Zalups RK: The Os/+ mouse: A genetic animal model of reduced renal mass. Am J Physiol 1993;264:F53-F60.
89. He C, Esposito C, Phillips C, Zalups RK, Henderson DA, Striker GE, Striker EJ: Dissociation of glomerular hypertrophy, cell proliferation, and glomerulosclerosis in mouse strains heterozygous for a mutation (Os) which induces a 50% reduction in nephron number. J Clin Invest 1996;97:1242-1249.
90. Lenz O, Zheng F, Vilar J, Doublier S, Lupia E, Schwedler S, Striker LJ, Striker GE: The inheritance of glomerulosclerosis in mice is controlled by multiple quantitative loci. Nephrol Dial Transplant 1998;13:3074-3078.
91. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 1998;339:1448-1456.
92. Bruijn JA, Hogendorn PCW, Corver WE, van Elven EH, Hodemaker PJ, Fleuren GJ: Renal pathology and characterization of glomerular sclerosis in murine chronic graft-versus-host disease. Nephrol Dial Transplant 1987;2: 422-427.
93. Han JS, Doi K: Morphometric study on the renal glomeruli of streptozotocin (SZ)-induced diabetic APA hamsters. Histol Histopathol 1992;7:549-554.
94. Honoi K, Doi K, Mitsuoka T: Histopathology of streptozotocin-induced diabetic DBA/2N and CD-1 mice. Lab Anim 1986;20:298-303.
95. Steffens MW, Maurer SM: Diabetic glomerulopathy in man and experimental models. Int Rev Exp Pathol 1984;26:147-175.
96. Kume E, Doi C, Itagaki SI, Nagashima Y, Doi K: Glomerular lesions in unilateral nephrectomized and diabetic (UN-D) mice. J Vet Med Sci 1992;54:1085-1090.
97. Velasquez MT, Kimmel PL, Michaelis OE: Animal models of spontaneous diabetic kidney disease. FASEB J 1990;4:2850-2859.
98. Doi T, Hattori M, Agodoa LY, Sato T, Yoshida H, Striker LJ, Striker GE: Glomerular lesions in nonobese diabetic mouse: Before and after the onset of hyperglycemia. Lab Invest 1990;63:204-212.
99. Yang CW, Hattori M, Vlassara H, He CJ, Carome MA, Yamato E, Elliot S, Striker GE, Striker LJ: Overexpression of transforming growth factor-beta 1 mRNA in associated with up-regulation of glomerular tenascin and laminin gene expression in nonobese diabetic mice. J Am Soc Ncphrol 1995;5:1610-1617.
100. Gartner K: Glomerular hyperfiltration during the onset of diabetes mellitus in two strains of diabetic mice (C57BL/6J db/db and C57BL/ KsJ db/db). Diabctologia 1978;15:59-63.
101. Cohen MP, Clements RS, Hud E, Cohen JA, Ziyadeh FN: Evolution of renal function abnormalities in the db/db mouse that parallels the development or human diabetic nephropathy. Exp Nephrol 1996;4:166-171.
102. Lubec B, Rokitansky A, Hayde M, Aufricht C, Wagner U, Mallinger WR, Hoger H, Lubec G: Thiaproline reduces glomerular basement membrane thickness and collagen accumulation in the db/db mouse. Nephron 1994;66: 333-336.
103. Wehner H, Hohn D, Faix-Schade U, Huber H, Walzer P: Glomerular changes in mice with spontaneous hereditary diabetes. Lab Invest 1972;27:331-340.
104. Melez KA, Harrison LC, Gilliam JN, Steinberg AD: Diabetes is associated with autoimmunity in the New Zealand obese (NZO) mouse. Diabetes 1980;24:835-840.
105. Sumida T, Furukawa M, Sakamoto A, et al: Prevention of insulitis and diabetes in beta-2-microglobulin-deficient non-obese diabetic mice. Int Immunol 1994;6:1445-1449.
106. Kelly CJ, Neilson EG: Tubulointerstitial disease: in Brenner BM (ed): The Kidney. Philadelphia, Saunders, 1996, pp 1655-1680.
107. Wilson CB: Immune models of tubulointerstitial injury; in Neilson EG, Couser WC (eds): Immunologic Renal Diseases. New York, Lippincott-Raven, 1997, pp 775-804.
108. Neilson EG, McCafferty E, Feldman A, Clayman MD, Zakheim B, Korngold R: Spontaneous interstitial nephritis in kdkd mice. I. An experimental model of autoimmune renal disease. J Immunol 1984;133:2560-2565.
109. Kelly CJ, Korngold R, Mann R, Clayman M, Haverly T, Neilson EG: Spontaneous interstitial nephritis in kdkd mice. II. Characterization of a tubular antigen-specific. H-2K-restricted Lyt-2+ effector T cell that mediates destructive tubulointerstitial injury. J Immunol 1986;136:526-531.
110. Rudofsky UH, Dilwith RL, Tung KSK: Susceptibility differences in inbred mice to induction of autoimmune renal tubulointerstitial lesions. Lab Invest 1980;43:463-470.
111. Neilson EG, McCafferty E, Mann R, Michaud L, Clayman M: Murine interstitial nephritis. III. The selection of phenotypic (Lyt and L3T4) and idiotypic (RE-Id) T cell preferences by genes in IgH-1 and H-2K characterizes the cell-mediated potential for disease expression: Susceptible mice provide a unique effector T cell repertoire in response to tubular antigen. J Immunol 1985;134: 2375-2382.
112. Rubin-Kelley VE, Jevnikar AM: Antigen presentation by renal tubular epithelial cells. J Am Soc Nephrol 1991;2:13-16.
113. Zagheim B, McCafferty E, Phillips SM, Clayman M, Neilson EG: Murine interstitial nephritis. II. The adoptive transfer of disease with immune T lymphocytes produces a phenotypically complex interstitial lesion. J Immunol 1984;133:234-239.
114. Harris KPG, Klahr S, Schreiner G: Obstructive nephropathy: From mechanical disturbance to immune activation? Exp Nephrol 1993;1:198-204.
115. Steinhardt GF, Ramon G, Salinas-Madrigal L: Glomerulosclerosis in obstructive uropathy. J Urol 1988;140:1316-1318.
116. Fern RJ, Yesko CM, Thornhill BA, Kim HS, Smithies O, Chevalier RL: Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice. J Clin Invest 1999;103:39-46.
117. Lee BJ, Boring L, Hwang O, Tomaszewski JE, Charo I, Danoff TM: Obstructive nephropathy in CCR2-deficient mice (abstract). J Am Soc Nephrol 1998;9:2455.
118. Miao J, Roberts ISD, Schiffer M, Bottinger EP: Unilateral ureter obstruction (UUO) in mice with deletion of one allele of TGF-beta (abstract 2184). J Am Soc Nephrol 1998;9: 427.
119. Yamasaki Y, Danoff T, Iwano M, Takahashi K, Neilson E: B7 on tubular epithelial cells accelerate local inflammation and may trigger autoimmune reaction (abstract 2406). J Am Soc Nephrol 1998;9:470.
120. Ma J, Nishimura H, Fogo A, Kon V, Inagami T, Ichikawa I: Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction. Kidney Int 1998;53:937-944.
121. Thadhani R, Pascual M, Bonventre JV: Acute renal failure. N Engl J Med 1996;334:1448-1460.
122. Ling H, Edelstein C, Gengaro P, Meng X, Lucia S, Knotek M, Wangsiripaisan A, Shi Y, Schrier R: Attenuation of renal ischemia-reperfusion injury in inducible nitric oxide synthase knockout mice. Am J Physiol 1999; 277:F383-F390.
123. Nogae S, Miyazaki M, Kobayashi N, Saito T, Abe K, Saito H, Nakane PK, Nakanishi Y, Koji T: Induction of apoptosis in ischemia-reperfusion model of mouse kidney: Possible involvement of Fas. J Am Soc Nephrol 1998; 9:620-631.
124. Ouellette AJ, Malt RA, Sukhatme VP, Bonventre JV: Expression of two 'immediate early' genes, Egr-1 and c-fos, in response to renal ischemia and during compensatory renal hypertrophy in mice. J Clin Invest 1990;85: 766-771.
125. Haq M, Norman J, Saba SR, Ramirez G, Rabb H: Role of II-1 in renal ischemic reperfusion injury. J Am Soc Nephrol 1998;9:614-619.
126. Kelly KJ, Williams WW, Colvin RB, Mechan SM, Springer TA, Gutierrez-Ramos JC, Bonventre JV: Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 1996;97:1056-1063.
127. Rabb H, Ramirez G, Saba SR, Reynolds D, Xu J, Flavell R, Antonia S: Renal ischemic-reperfusion injury in L-selectin-deficient mice. Am J Physiol 1996;271:F408-F413.
128. Zager RA, Conrad S, Lochhead K, Sweeney EA, Igarashi Y, Burkhart KM: Altered sphingomyelinase and ceramide expression in the setting of ischmic and nephrotoxic acute renal failure. Kidney Int 1998;53:573-582.
129. Parchure M, Ambaye RY, Lalitha VS, Gokhale SV: Acute toxicity of folic acid in mice. Exprientia 1985;15:72-73.
130. Calvet JP, Chadwick LJ: Primary and secondary genetic responses after folic acid-induced acute renal injury in the mouse. J Am Soc Nephrol 1994;5:1324-1332.
131. Cowley BD, Chadwick LJ, Grantham JJ, Calvel JP: Sequential protooncogene expression in regenerating kidney following acute renal injury. J Biol Chem 1989;15:8389-8393.
132. Kujubu DA: Differences in 'primary response' gene expression in renal compensatory hypertrophy and hyperplasia. Am J Kidney Dis 1991;17:641-643.
133. Zager RA: Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 1996;49:314-326.
134. Ponraj D, Gopalakrishnakone P: Establishment of an animal model for myoglobinuria by use of a myotoxin from Pseudechis australis (king brown snake) venom in mice. Lab Anim Sci 1996;46:393-398.
135. Ponraj D, Gopalakrishnakone P: Renal lesions in rhabdomyolysis caused by Pseudechis australis snake myotoxin. Kidney Int 1997; 51:1956-1969.
136. Hata A, Tsunoo H, Nakajima H, Sgintaku K, Kimura M: Acute cadmium intoxication in inbred mice: A study on strain differences. Chem Biol Interact 1980;32:29-39.
137. Dorian C, Gattone VH, Klassen CD: Discrepancy between the nephrotoxic potencies of cadmium-metallothionein and cadmium chloride and the renal concentration of cadmium in the proximal convoluted tubules. Toxicol Appl Pharmacol 1995;130:161-168.
138. Maitani T, Cuppage FE, Klaassen CD: Nephrotoxicity of intravenously injected cadmium-metallothionein: Critical concentration and tolerance. Fundam Appl Toxicol 1988;10:98-108.
139. Diamond GL, Zalups RK: Understanding renal toxicity of heavy metal. Toxicol Pathol 1998;26:92-103.
140. Moszczynski P: Mercury compounds and the immune system: A review. Int J Occup Med Environ Health 1997;10:247-258.
141. Nielsen JB, Andersen HR, Andersen O, Starklint H: Dose and time relation in Hg (++)-induced tubular necrosis and regeneration. Environ Health Perspect 1994;102 (suppl 3):317-320.
142. Tanaka T, Naganuma A, Imura N: Role of gamma-glutamyltranspeptidase in renal uptake and toxicity of inorganic mercury in mice. Toxicology 1990;60:187-198.
143. Gabizon D, Goren E, Shaked U, Averbukh Z, Rosenmann E, Modai D: Induction of chronic renal failure in the mouse: A new model. Nephron 1985;40:349-352.
144. Gibb IA, Hamilton DN: An experimental model of chronic renal failure in mice. Clin Immunol Immunopathol 1985;35:276-284.
145. Kren S, Hostetter TH: The course of the remnant kidney model in mice. Kidney Int 1999; 56:333-337.
146. Gagnon RF, Gallimore B: Characterization of chronic uremia. Urol Res 1988;16:119-126.
147. Banchaabouchi MA, Marescau B, D'Hooge R, Van Marck E, Van Daele A, Levillain O, DC Deyn PP: Biochemical and histopathological changes in nephrectomized mice. Metabolism 1998;47:355-361.
148. Gagnon RF, Ansari M: Development and progression of uremic changes in the mouse with surgically induced renal failure. Nephron 1990;54:70-76.
149. Gagnon RF, Gold J, Gerstein W: A mouse model of delayed-type hypersensitivity skin changes in chronic renal failure. Uremia Invest 1984;8:121-125.
150. Brox AG, Zhang F, Guyda H, Gagnon RF: Subtherapeutic crythropoietin and insulin-like growth factor-1 correct the anemia of chronic renal failure in the mouse. Kidney Int 1996;50:937-943.